S. Kruger, M. Ilmer, S. Kobold, B. L. Cadilha, S. Endres et al., Advances in cancer immunotherapy 2019 -latest trends, J Exp Clin Cancer Res, vol.38, p.268, 2019.

D. Gregorio, E. Caproni, E. Ulmer, and J. B. , Vaccine adjuvants: mode of action, Front Immunol, vol.4, p.214, 2013.

W. S. Bowen, A. K. Svrivastava, L. Batra, H. Barsoumian, and H. Shirwan, Current challenges for cancer vaccine adjuvant development, Exp Rev Vaccines, vol.17, pp.207-222, 2018.

B. S. Powell, A. K. Andrianov, and P. C. Fusco, Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes, Clin Exp Vaccine Res, vol.4, pp.23-45, 2015.

V. A. Kabanov, From synthetic polyelectrolytes to polymer-subunit vaccines, Pure Appl Chem, vol.76, pp.1659-77, 2004.

P. Pru?inec, N. Chirun, and A. Sveikata, The safety profile of Polyoxidonium in daily practice: results from postauthorization safety study in Slovakia, Immunotherapy, vol.10, pp.131-138, 2018.

V. A. Dyakonova, S. V. Dambaeva, B. V. Pinegin, and R. M. Khaitov, Study of interaction between the polyoxidonium immunomodulator and the human immune system cells, Int Immunopharmacol, vol.4, pp.1615-1638, 2004.

S. V. Dambaeva, D. V. Mazurov, N. M. Golubeva, D. Va, B. V. Pinegin et al., Effect of polyoxidonium on the phagocytic activity of human peripheral blood leukocytes, Russ J Immunol, vol.8, pp.53-60, 2003.

A. Toptygina, E. Semikina, and V. Alioshkin, Influence of an immunopotentiator Polyoxidonium on cytokine profile and antibody production in children vaccinated with Priorix, Arch Physiol Biochem, vol.118, pp.197-203, 2012.

T. B. Fessenden, E. Duong, and S. Spranger, A team effort: natural killer cells on the first leg of the tumor immunity relay race, J Immunother Cancer, vol.6, p.67, 2018.

C. Webber, M. Gospodarowicz, L. H. Sobin, C. Wittekind, F. L. Greene et al., Improving the TNM classification: findings from a 10-year continuous literature review, Int J Cancer, vol.135, pp.371-379, 2014.

V. D. Ermilova, T. L. Koposova, N. I. Murav'ëva, and Z. V. Kuz'mina, Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer

, Vopr Onkol, vol.31, pp.69-73, 1985.

N. A. Semenova, I. Y. Dydykina, L. Y. Dederer, A. G. Tikhomirov, V. A. Gorbunova et al., The use of 1H-NMR spectroscopy for predicting the efficiency of neoadjuvant chemotherapy of breast cancer, Bull Exp Biol Med, vol.130, pp.701-705, 2000.

D. Sanchez-martinez, A. Vega, N. Orecchioni, S. Talarico, G. Cornillon et al., Expansion of allogeneic NK cells with efficient antibodydependent cell cytotoxicity against multiple tumor cells, Theranostic, vol.8, pp.3856-69, 2018.

D. N. Vo, A. C. Allende-vega, N. Morschhauser, F. Houot, R. Menard et al., NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment, Oncoimmunology, vol.7, p.1409322, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01780378

J. I. Aguilo, J. Garaude, J. Pardo, M. Villalba, and A. Anel, Protein kinase Ctheta is required for NK cell activation and in vivo control of tumor progression, J Immunol, vol.182, pp.1972-81, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02194087

D. Sanchez-martinez, G. Azaceta, A. Muntasell, N. Aguilo, D. Nunez et al., Human NK cells activated by EBV lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells, Oncoimmunology, vol.4, p.991613, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01835574

M. Villalba, M. G. Rathore, N. Lopez-royuela, E. Krzywinska, J. Garaude et al., From tumor cell metabolism to tumor immune escape, Int J Biochem Cell Biol, vol.45, pp.106-119, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00726717

A. Anel, J. I. Aguilo, E. Catalan, J. Garaude, M. G. Rathore et al., Protein kinase C-theta (PKC-theta) in natural killer cell function and antitumor immunity, Front Immunol, vol.3, p.187, 2012.

D. M. Strauss-albee and C. A. Blish, Human NK cell diversity in viral infection: ramifications of ramification, Front Immunol, vol.7, p.66, 2016.

E. Krzywinska, N. Allende-vega, A. Cornillon, D. N. Vo, L. Cayrefourcq et al., Identification of anti tumor cells carrying natural killer (NK) cell antigens in patients with hematological cancers, EBioMedicine, vol.2, pp.1364-76, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01867114

E. Krzywinska, A. Cornillon, N. Allende-vega, D. N. Vo, R. C. Lu et al., CD45 isoform profile identifies natural killer (NK) subsets with differential activity, PLoS ONE, vol.11, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01867110

Y. T. Bryceson, S. C. Chiang, S. Darmanin, C. Fauriat, H. Schlums et al., Molecular mechanisms of natural killer cell activation, J Innate Immun, vol.3, pp.216-242, 2011.

K. Juelke, M. Killig, M. Luetke-eversloh, E. Parente, J. Gruen et al., CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells, Blood, vol.116, pp.1299-307, 2010.

S. Lopez-verges, J. M. Milush, S. Pandey, V. A. York, J. Arakawa-hoyt et al., CD57 defines a functionally distinct population of mature NK cells in the human CD56 dim CD16 + NK-cell subset, Blood, vol.116, pp.3865-74, 2010.

A. M. Abel, C. Yang, M. S. Thakar, and S. Malarkannan, Natural killer cells: development, maturation, and clinical utilization, Front Immunol, vol.9, p.1869, 2018.

R. Kaplan, B. Morse, K. Huebner, C. Croce, R. Howk et al., Cloning of three human tyrosine phosphatases reveals a multigene family of receptorlinked protein-tyrosine-phosphatases expressed in brain, Proc Natl Acad Sci, vol.87, pp.7000-7004, 1990.

Q. Chen, T. Li, and W. Yue, Drug response to PD-1/PD-L1 blockade: based on biomarkers, OncoTargets Ther, vol.11, pp.4673-83, 2018.

D. B. Fogel, Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review, Contemp Clin Trials Commun, vol.11, pp.156-64, 2018.

D. Carter and S. G. Reed, Role of adjuvants in modeling the immune response, Curr Opin HIV AIDS, vol.5, pp.409-422, 2010.

I. Rhee and A. Veillette, Protein tyrosine phosphatases in lymphocyte activation and autoimmunity, Nat Immunol, vol.13, pp.439-486, 2012.

T. Mustelin, T. Vang, and N. Bottini, Protein tyrosine phosphatases and the immune response, Nat Rev Immunol, vol.5, pp.43-57, 2005.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai et al., Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, vol.26, pp.1275-81, 2008.